Related references
Note: Only part of the references are listed.Dietary curcumin counteracts extracellular transthyretin deposition: Insights on the mechanism of amyloid inhibition
Nelson Ferreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy
Nelson Ferreira et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2012)
Transthyretin Deposition in Familial Amyloidotic Polyneuropathy
M. J. Saraiva et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?
S. K. Palaninathan
CURRENT MEDICINAL CHEMISTRY (2012)
The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug
Steven M. Johnson et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade
Christine E. Bulawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Dissecting the Structure, Thermodynamic Stability, and Aggregation Properties of the A25T Transthyretin (A25T-TTR) Variant Involved in Leptomeningeal Amyloidosis: Identifying Protein Partners That Co-Aggregate during A25T-TTR Fibrillogenesis in Cerebrospinal Fluid
Estefania P. C. Azevedo et al.
BIOCHEMISTRY (2011)
Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation
Nelson Ferreira et al.
FEBS LETTERS (2011)
Heparin Induces Harmless Fibril Formation in Amyloidogenic W7FW14F Apomyoglobin and Amyloid Aggregation in Wild-Type Protein In Vitro
Silvia Vilasi et al.
PLOS ONE (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Identification of a novel ligand binding motif in the transthyretin channel
Luis Mauricio T. R. Lima et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: effect of tetracycline and trehalose
Ivana Sirangelo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors
Teresa Mairal et al.
PLOS ONE (2009)
Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias
Thomas C. Terwilliger et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2008)
Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies
Steven M. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Structural Insight into pH-induced Conformational Changes within the Native Human Transthyretin Tetramer
Satheesh K. Palaninathan et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Design of mechanism-based inhibitors of transthyretin amyloidosis: Studies with biphenyl ethers and new structural templates
Sarika Gupta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Transthyretin and familial amyloidotic polyneuropathy - Recent progress in understanding the molecular mechanism of neurodegeneration
Xu Hou et al.
FEBS JOURNAL (2007)
Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis
Kana Tojo et al.
NEUROSCIENCE RESEARCH (2006)
Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin
Yraima Cordeiro et al.
BIOPHYSICAL JOURNAL (2006)
Probing protein folding and conformational transitions with fluorescence
Catherine A. Royer
CHEMICAL REVIEWS (2006)
Is one solution good enough?
N Furnham et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Tetracycline inhibits W7FW14F apomyoglobin fibril extension and keeps the amyloid protein in a pre-fibrillar, highly cytotoxic state
Clorinda Malmo et al.
FASEB JOURNAL (2006)
The pathway by which the tetrameric protein transthyretin dissociates
TR Foss et al.
BIOCHEMISTRY (2005)
The biological and chemical basis for tissue-selective amyloid disease
Y Sekijima et al.
CELL (2005)
High pressure studies on transthyretin
D Foguel
PROTEIN AND PEPTIDE LETTERS (2005)
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture
N Reixach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: Results from the familial amyloidotic polyneuropathy world transplant registry
G Herlenius et al.
TRANSPLANTATION (2004)
PRODRG:: a tool for high-throughput crystallography of protein-ligand complexes
AW Schüttelkopf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative
MR Almeida et al.
BIOCHEMICAL JOURNAL (2004)
Developments in the CCP4 molecular-graphics project
L Potterton et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization
AR Hurshman et al.
BIOCHEMISTRY (2004)
Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants
SR Miller et al.
LABORATORY INVESTIGATION (2004)
D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid:: A prescription for central nervous system amyloidosis?
P Hammarström et al.
BIOCHEMISTRY (2003)
Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease
AD Ferrao-Gonzales et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology
Y Sekijima et al.
LABORATORY INVESTIGATION (2003)
Spontaneous aggregation and cytotoxicity of the beta-amyloid A beta(1-40): A kinetic model
BM Taylor et al.
JOURNAL OF PROTEIN CHEMISTRY (2003)
Sequence-dependent denaturation energetics:: A major determinant in amyloid disease diversity
P Hammarström et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Only amyloidogenic intermediates of transthyretin induce apoptosis
K Andersson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Screening transthyretin amyloid fibril inhibitors: Characterization of novel multiprotein, multiligand complexes by mass spectrometry
MG McCammon et al.
STRUCTURE (2002)
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
M Bucciantini et al.
NATURE (2002)
Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors
VB Oza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured
X Jiang et al.
BIOCHEMISTRY (2001)
Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants
A Quintas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A comparative analysis of 23 structures of the amyloidogenic protein transthyretin
A Hörnberg et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
The preaggregated state of an amyloidogenic protein: Hydrostatic pressure converts native transthyretin into the amyloidogenic state
AD Ferrao-Gonzales et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
